Ocata Therapeutics Inc fka OCAT

[ddls]

Let say for conservative sake.

They have 500 million shares at their disposal to dump
a little at a time on the market.
That adds up to $75 million dollars @ .15 per share.

Even if they have only 300 million shares, that's $45 million
dollars for them to run on.

At some point one has to ask, why are they totally relaying on
share holders to support them, when there should be good private
equity available given the science and potential?

Or, a good JV?

If they have not acquired a JV or private equity group, then
they will dilute more shares if they run out of their existing
monies.

Now, I'm kinda wondering why a company like Dendreon existed on
the Nasdaq for so long, burning tons of cash?